Home » Cellegy to Seek More Cash After $28M Loss; CFO Quits
Cellegy to Seek More Cash After $28M Loss; CFO Quits
April 4, 2005
Cellegy Pharmaceuticals said Tuesday its accountants will include a going concern qualification in its annual 10-K financial report, and that it will seek to raise money through partnership with other drug companies or through equity or debt financing. The company also said its chief financial officer, Richard Juelis, quit "to pursue other interests." The Brisbane company lost $28.2 million on revenue of $2.6 million for the year ended December, compared with a loss of $13.5 million on revenue of $1.6 million in 2003.
Bizjournals (http://www.bizjournals.com/industries/health_care/pharmaceuticals/2005/03/28/sanfrancisco_daily17.html)
KEYWORDS FDAnews Drug Daily Bulletin
Upcoming Events
-
21Oct